Singlera
China · Founded 2014 · $60.0M raised
- Founded
- 2014
- Business Model
- B2B
- Website
- singlera.com.cn
- Total Funding
- $60.0M
- Last Round
- $60.0M Extension RoundMar 2018
- Rounds
- 1
About
Singlera Genomics, founded in 2014, is a DNA-methylation tumor molecular testing company focused on cancer early screening and liquid biopsy. It develops diagnostics covering the cancer care cycle from early detection and diagnosis through recurrence prediction and monitoring, with a pipeline spanning multi-cancer, colorectal, liver, gastric, esophageal, and pancreatic cancers. Group headquarters were established in Shanghai in 2015, and the company commercializes IVD reagents plus research services for hospitals and clinical partners across China.
Summary
Singlera is a Biotech company based in China, founded in 2014. It has raised $60.0M in total across 1 round, most recently a $60.0M Extension Round round in Mar 2018. Investors include Green Pine Capital Partners.
Funding History
Mar 2018
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/singlera"><img src="https://indexed.vc/api/badge/company/singlera" alt="Singlera on Indexed.vc" width="260" height="76" /></a>